19 August, 2025

Singapore
Singapore develops blood test to improve prediction of gestational diabetes

Researchers from the Global Centre for Asian Women’s Health (GloW) and the Department of Obstetrics and Gynecology...Read more

- 18 August 2025 News

Korea
Korea's GC Biopharma signs MoU with Thai Red Cross Society to strengthen collaboration on plasma-derived therapies

GC Biopharma, a South Korean biopharmaceutical company, has signed a Memorandum of Understanding (MoU) with the Thai Red...Read more

- 18 August 2025 News


Australia
Australian startup Mirugen secures upto AU$4.5 M seed funding for pioneering cell reprogramming


Mirugen, a preclinical biotechnology startup (re)programming cells to unlock innate cellular repair mechanisms, has a...Read more

- 18 August 2025 News


China
Japan's Eisai launches in-house developed anti-insomnia drug DAYVIGO(R) (Lemborexant) in China


Eisai Co. has announced that the in-house discovered and developed orexin receptor antagonist DAYVIGO® (brand name i...Read more

- 18 August 2025 News


World
Skyhawk Therapeutics inks $2 B deal with Merck to discover novel RNA-targeting small molecules for neurological disorders


US-based startup Skyhawk Therapeutics, Inc., a leader in the discovery and development of small molecules that modulate ...Read more

- 18 August 2025 News





All you want to read on

North America Europe Asia Pacific
South East Asia SAARC Middle East



This email has been sent to you in association with
www.biospectrumasia.com
Tell Us What You Think! Help us improve our newsletters.
Send us your feedback!
© Copyright 2025 MM ACTIV. All rights reserved.
To Unsubscribe click here.

Disclaimer : Please remember – by opting-in you are still able to opt-out at any time, by simply replying to this email at digital@mmactiv.com and typing 'unsubscribe' in the 'subject' field of any future emails. We promise only to send emails that we believe you will find interesting, relevant and current.
Your data will never be sold or shared with any third party, although we may communicate a message to you from a partner that we are in collaboration with.